CABALETTA BIO INC (CABA) Stock Income Statement
NASDAQ:CABA - Nasdaq - US12674W1099 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 125.14M | 74.66M | 54.14M | 46.31M | 33.83M | |||
| Research and Development | 97.20M | 55.42M | 39.30M | 32.49M | 21.38M | |||
| Selling, General, and Administrative Expenses | 27.94M | 19.24M | 14.84M | 13.82M | 12.46M | |||
| Operating Income | -125.14M | -74.66M | -54.14M | -46.31M | -33.83M | |||
| Interest Income/Expense | 9.28M | 6.99M | 1.16M | 20.00K | 490.00K | |||
| Other Income/Expense | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -115.86M | -67.67M | -52.98M | -46.29M | -33.34M | |||
| Net Income | -115.86M | -67.67M | -52.98M | -46.29M | -33.34M | |||
| EBITDA | -120.33M | -73.23M | -52.96M | -45.58M | -33.48M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.34 | -1.65 | -1.81 | -1.80 | -1.44 | |||
| Non GAAP EPS | -2.34 | -1.65 | -1.81 | -1.80 | -1.44 | |||
| Statistics | ||||||||
All data in USD